Journey Medical Corp
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +24.5% | +40.9% | +79.4% | -38.6% | -90.2% | +53.3% | +87.4% | +8.1% | -26.9% | +4.4% | +17.9% | |
| – | +106.0% | +30.7% | +96.0% | -39.7% | -92.5% | +39.5% | +139.8% | -8.1% | -27.3% | -14.7% | +38.8% | |
| – | +93.7% | -61.0% | +608.1% | -64.5% | -95.4% | +71.8% | +495.2% | -34.8% | -14.3% | -26.0% | +18.6% | |
| – | +121.0% | +17.3% | +118.7% | -43.2% | -98.5% | +71.8% | +495.2% | -34.8% | -14.3% | -26.0% | +18.6% | |
| – | – | – | -99.8% | +10,907.7% | +231.1% | +26.2% | -3.4% | +22.0% | -46.0% | -32.8% | +191.1% | |
| – | – | – | – | – | -89.8% | +63.8% | +602.4% | +43.6% | -27.9% | +41.4% | -33.3% | |
| – | – | – | – | – | – | +96.6% | -49.1% | +112.4% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | – | – | – | – | – | – | – | |
| – | -68.0% | +0.0% | +0.0% | -15.5% | +674.9% | +103.7% | -16.5% | +116.7% | -25.4% | +57.1% | -13.4% | |
| – | +47.9% | +78.9% | +530.3% | -14.1% | -91.2% | +33.8% | +32.7% | +59.6% | -35.9% | +6.5% | +4.3% | |
| – | +117.8% | +35.1% | +201.1% | -63.4% | -45.8% | +34.3% | +83.9% | +29.5% | -37.4% | -16.0% | +6.4% | |
| – | +68.8% | +181.9% | +53.0% | – | – | +5,450.6% | +17.6% | -44.1% | +2.2% | -77.2% | -85.7% | |
| – | +65.9% | +46.3% | +11.8% | +5.7% | -86.8% | -7.2% | +1,066.3% | +62.1% | -56.5% | -0.2% | -42.0% | |
| – | – | – | – | – | – | +0.0% | – | – | -26.2% | +70.1% | +1.6% | |
| – | +20.8% | +33.4% | -39.5% | -106.0% | – | +274.0% | +308.5% | -59.6% | +19.8% | -1.4% | +58.7% | |
| – | – | – | – | – | – | – | -859.3% | – | – | – | – | |
| – | +8.4% | +23.6% | +22.7% | +3.6% | -60.3% | +0.0% | +3.9% | +1.2% | +4.0% | +12.1% | +19.9% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.